DK95279A - Fremgangsmaade til fremstilling af nye urinstof-og amidoforbindelser - Google Patents

Fremgangsmaade til fremstilling af nye urinstof-og amidoforbindelser

Info

Publication number
DK95279A
DK95279A DK95279A DK95279A DK95279A DK 95279 A DK95279 A DK 95279A DK 95279 A DK95279 A DK 95279A DK 95279 A DK95279 A DK 95279A DK 95279 A DK95279 A DK 95279A
Authority
DK
Denmark
Prior art keywords
procedure
preparing new
amido compounds
new urine
urine
Prior art date
Application number
DK95279A
Other languages
English (en)
Inventor
A Marxer
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DK95279A publication Critical patent/DK95279A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95279A 1978-03-08 1979-03-07 Fremgangsmaade til fremstilling af nye urinstof-og amidoforbindelser DK95279A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH251978 1978-03-08

Publications (1)

Publication Number Publication Date
DK95279A true DK95279A (da) 1979-09-09

Family

ID=4235609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95279A DK95279A (da) 1978-03-08 1979-03-07 Fremgangsmaade til fremstilling af nye urinstof-og amidoforbindelser

Country Status (28)

Country Link
US (2) US4292429A (da)
EP (1) EP0004561B1 (da)
JP (1) JPS54125668A (da)
KR (2) KR820002098B1 (da)
AR (2) AR225010A1 (da)
AT (1) AT364375B (da)
AU (1) AU531006B2 (da)
CS (1) CS244656B2 (da)
CY (1) CY1304A (da)
DD (1) DD142336A5 (da)
DE (1) DE2961198D1 (da)
DK (1) DK95279A (da)
ES (1) ES478342A1 (da)
FI (1) FI70708C (da)
GB (1) GB2016011B (da)
GR (1) GR71998B (da)
HK (1) HK80185A (da)
HU (1) HU182940B (da)
IL (1) IL56797A (da)
MY (1) MY8700199A (da)
NO (1) NO152606C (da)
NZ (1) NZ189841A (da)
OA (1) OA06201A (da)
PH (1) PH16207A (da)
PL (2) PL123150B1 (da)
PT (1) PT69314A (da)
SU (2) SU845779A3 (da)
ZA (1) ZA791062B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338453A (en) 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
DE3213509A1 (de) * 1982-04-10 1983-10-20 Basf Ag, 6700 Ludwigshafen N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
AU5234886A (en) * 1984-12-12 1986-07-01 MTD-Produkter I Smaland A.B. Method of preparing a hospital room or the like
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds
NZ563054A (en) * 2005-05-03 2010-09-30 Pharma Mar Sa Antitumoral tetrahydro-pyrimidines
FR2901273B1 (fr) 2006-05-19 2010-12-24 Anaconda Pharma Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
NZ592264A (en) 2008-09-17 2013-10-25 William Kingston Tideway anchor system
BR112012021657B8 (pt) 2010-03-04 2022-06-07 Ea Pharma Co Ltd Composto, agente farmacêutico, agente para conferir kokumi , e, tempero
WO2011108724A1 (ja) * 2010-03-04 2011-09-09 味の素株式会社 糖尿病又は肥満症の予防又は治療剤
CN102924380B (zh) * 2012-11-13 2014-12-31 齐鲁动物保健品有限公司 一种咪唑苯脲的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH234990A (de) * 1938-05-11 1944-10-31 Chem Ind Basel Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins.
GB813525A (en) * 1956-07-09 1959-05-21 Socony Mobil Oil Co Inc Fuel oil composition
GB1082964A (en) * 1963-06-25 1967-09-13 Wellcome Found New substituted imidazolines and their preparation and use
US3455940A (en) * 1965-12-07 1969-07-15 Herbert C Stecker Certain halo and dihalo n-substituted salicylamides
GB1174349A (en) * 1966-08-25 1969-12-17 Boehringer Sohn Ingelheim Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
US3846071A (en) * 1969-02-12 1974-11-05 Petrolite Corp Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts
NL7415845A (nl) * 1973-12-26 1975-06-30 Upjohn Co Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten.
US4088766A (en) * 1975-06-25 1978-05-09 The Upjohn Company Urea containing compositions and methods
US4233451A (en) * 1976-05-20 1980-11-11 The Procter & Gamble Company Process for making imidazolinium salts
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use

Also Published As

Publication number Publication date
PL123150B1 (en) 1982-09-30
EP0004561A3 (en) 1979-11-14
ZA791062B (en) 1980-03-26
ATA171079A (de) 1981-03-15
NO152606B (no) 1985-07-15
AR225010A1 (es) 1982-02-15
AU4490079A (en) 1979-09-13
KR820002098B1 (ko) 1982-11-05
PH16207A (en) 1983-08-05
CS244656B2 (en) 1986-08-14
FI790740A (fi) 1979-09-09
OA06201A (fr) 1981-06-30
AU531006B2 (en) 1983-08-04
JPS54125668A (en) 1979-09-29
FI70708C (fi) 1986-10-06
DD142336A5 (de) 1980-06-18
NO152606C (no) 1985-10-23
KR830000884B1 (ko) 1983-04-26
PL213924A1 (da) 1980-02-25
EP0004561B1 (de) 1981-11-04
DE2961198D1 (en) 1982-01-14
US4292429A (en) 1981-09-29
PL116762B1 (en) 1981-06-30
GB2016011A (en) 1979-09-19
AR227286A1 (es) 1982-10-15
SU845779A3 (ru) 1981-07-07
HK80185A (en) 1985-10-25
NO790765L (no) 1979-09-11
HU182940B (en) 1984-03-28
SU923367A3 (ru) 1982-04-23
US4420619A (en) 1983-12-13
CY1304A (en) 1985-12-06
GR71998B (da) 1983-08-26
MY8700199A (en) 1987-12-31
PT69314A (de) 1979-04-01
JPS629109B2 (da) 1987-02-26
ES478342A1 (es) 1979-05-16
GB2016011B (en) 1982-08-25
IL56797A (en) 1982-09-30
AT364375B (de) 1981-10-12
NZ189841A (en) 1982-03-09
EP0004561A2 (de) 1979-10-17
FI70708B (fi) 1986-06-26

Similar Documents

Publication Publication Date Title
DK158679C (da) Fremgangsmaade til fremstilling af ethanol
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK54879A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK140480A (da) Fremgangsmaade til fremstilling af mercaptoacyldipeptider
DK229980A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-thienamyciner
DK540180A (da) Fremgangsmaade til fremstilling af acetamider
DK95279A (da) Fremgangsmaade til fremstilling af nye urinstof-og amidoforbindelser
DK320980A (da) Indretning til knusning af afgroeder
DK277880A (da) Fremgangsmaade til fremstilling af dipeptider
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK196579A (da) Fremgangsmaade til fremstilling af substituerede dibenzylethere
DK282379A (da) Fremgangsmaade til fremstilling af phenylpiperidinderivater isaer substituerede eventuelt enkeltmaettede 1-benzylphenylpiperidiner
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK169280A (da) Fremgangsmaade til fremstilling af nye alkoxyalkylidenhydrazinopyridaziner
DK569078A (da) Fremgangsmaade til fremstilling af nye arylaminoimidazolinderivater
DK127179A (da) Fremgangsmaade til fremstilling af monokaryoner
DK185179A (da) Fremgangsmaade til fremstilling af 3-halogen-2-hydroxyalkyltrialkylammoniumunchlorider
DK77577A (da) Fremgangsmade til fremstilling af nye amidinopenicillanoyloxyalkylcephalosporanater
DK153541C (da) Fremgangsmaade til fremstilling af n-ethylethylendiamin
DK147183C (da) Fremgangsmaade til fremstilling af l-alfa-glycerophosphatoxidase
DK18779A (da) Fremgangsmaade til fremstilling af estere

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
ARF Application refused